• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新的监督式机器学习预测分析在胶质瘤患者肿瘤切除术后生存情况中的应用:一家大型中国中心的经验

Practice of the new supervised machine learning predictive analytics for glioma patient survival after tumor resection: Experiences in a high-volume Chinese center.

作者信息

Li Yushan, Ye Maodong, Jia Baolong, Chen Linwei, Zhou Zubang

机构信息

Department of Ultrasound, Gansu Provincial Hospital, Lanzhou, China.

Medical Cosmetic Center, First Affiliated Hospital of Shantou University Medical College, Shantou, China.

出版信息

Front Surg. 2023 Feb 17;9:975022. doi: 10.3389/fsurg.2022.975022. eCollection 2022.

DOI:10.3389/fsurg.2022.975022
PMID:36873808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9981970/
Abstract

OBJECTIVE

This study aims to assess the effectiveness of the Gradient Boosting (GB) algorithm on glioma prognosis prediction and to explore new predictive models for glioma patient survival after tumor resection.

METHODS

A cohort of 776 glioma cases (WHO grades II-IV) between 2010 and 2017 was obtained. Clinical characteristics and biomarker information were reviewed. Subsequently, we constructed the conventional Cox survival model and three different supervised machine learning models, including support vector machine (SVM), random survival forest (RSF), Tree GB, and Component GB. Then, the model performance was compared with each other. At last, we also assessed the feature importance of models.

RESULTS

The concordance indexes of the conventional survival model, SVM, RSF, Tree GB, and Component GB were 0.755, 0.787, 0.830, 0.837, and 0.840, respectively. All areas under the cumulative receiver operating characteristic curve of both GB models were above 0.800 at different survival times. Their calibration curves showed good calibration of survival prediction. Meanwhile, the analysis of feature importance revealed Karnofsky performance status, age, tumor subtype, extent of resection, and so on as crucial predictive factors.

CONCLUSION

Gradient Boosting models performed better in predicting glioma patient survival after tumor resection than other models.

摘要

目的

本研究旨在评估梯度提升(GB)算法在胶质瘤预后预测中的有效性,并探索胶质瘤患者肿瘤切除术后生存的新预测模型。

方法

获取了2010年至2017年间776例胶质瘤病例(世界卫生组织II-IV级)。回顾了临床特征和生物标志物信息。随后,我们构建了传统的Cox生存模型和三种不同的监督机器学习模型,包括支持向量机(SVM)、随机生存森林(RSF)、树状GB和组件GB。然后,相互比较模型性能。最后,我们还评估了模型的特征重要性。

结果

传统生存模型、SVM、RSF、树状GB和组件GB的一致性指数分别为0.755、0.787、0.830、0.837和0.840。两个GB模型在不同生存时间的累积受试者工作特征曲线下面积均高于0.800。它们的校准曲线显示出生存预测的良好校准。同时,特征重要性分析显示卡诺夫斯基功能状态、年龄、肿瘤亚型、切除范围等是关键预测因素。

结论

梯度提升模型在预测胶质瘤患者肿瘤切除术后生存方面比其他模型表现更好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfd/9981970/be674565c8f0/fsurg-09-975022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfd/9981970/4bb88c31838e/fsurg-09-975022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfd/9981970/be674565c8f0/fsurg-09-975022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfd/9981970/4bb88c31838e/fsurg-09-975022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfd/9981970/be674565c8f0/fsurg-09-975022-g002.jpg

相似文献

1
Practice of the new supervised machine learning predictive analytics for glioma patient survival after tumor resection: Experiences in a high-volume Chinese center.新的监督式机器学习预测分析在胶质瘤患者肿瘤切除术后生存情况中的应用:一家大型中国中心的经验
Front Surg. 2023 Feb 17;9:975022. doi: 10.3389/fsurg.2022.975022. eCollection 2022.
2
A machine learning-based survival prediction model of high grade glioma by integration of clinical and dose-volume histogram parameters.基于机器学习的高级别胶质瘤临床和剂量-体积直方图参数整合的生存预测模型。
Cancer Med. 2021 Apr;10(8):2774-2786. doi: 10.1002/cam4.3838. Epub 2021 Mar 24.
3
The Application and Comparison of Machine Learning Models for the Prediction of Breast Cancer Prognosis: Retrospective Cohort Study.机器学习模型在乳腺癌预后预测中的应用与比较:回顾性队列研究
JMIR Med Inform. 2022 Feb 18;10(2):e33440. doi: 10.2196/33440.
4
A Comparison Study of Machine Learning (Random Survival Forest) and Classic Statistic (Cox Proportional Hazards) for Predicting Progression in High-Grade Glioma after Proton and Carbon Ion Radiotherapy.机器学习(随机生存森林)与经典统计学(Cox比例风险模型)预测质子和碳离子放疗后高级别胶质瘤进展的比较研究
Front Oncol. 2020 Oct 30;10:551420. doi: 10.3389/fonc.2020.551420. eCollection 2020.
5
Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?预测模型工具能否识别 ACL 重建术后阿片类药物使用时间延长的高风险患者?
Clin Orthop Relat Res. 2020 Jul;478(7):0-1618. doi: 10.1097/CORR.0000000000001251.
6
Prognosis prediction of extremity and trunk wall soft-tissue sarcomas treated with surgical resection with radiomic analysis based on random survival forest.基于随机生存森林的放射组学分析预测手术切除治疗肢体和躯干壁软组织肉瘤的预后。
Updates Surg. 2022 Feb;74(1):355-365. doi: 10.1007/s13304-021-01074-8. Epub 2021 May 18.
7
Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.机器学习和低级别胶质瘤的放射组学表型:改善生存预测。
Eur Radiol. 2020 Jul;30(7):3834-3842. doi: 10.1007/s00330-020-06737-5. Epub 2020 Mar 11.
8
Glioma Survival Prediction with Combined Analysis of In Vivo C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning.基于有监督机器学习的 C-MET PET 体内特征、体外特征和患者特征联合分析预测脑胶质瘤患者的生存情况
J Nucl Med. 2018 Jun;59(6):892-899. doi: 10.2967/jnumed.117.202267. Epub 2017 Nov 24.
9
The prediction of in-hospital mortality in chronic kidney disease patients with coronary artery disease using machine learning models.应用机器学习模型预测伴有冠状动脉疾病的慢性肾脏病患者的院内死亡率。
Eur J Med Res. 2023 Jan 18;28(1):33. doi: 10.1186/s40001-023-00995-x.
10
Machine learning based survival prediction in Glioma using large-scale registry data.基于机器学习的大型登记数据Glioma 生存预测。
Health Informatics J. 2022 Oct-Dec;28(4):14604582221135427. doi: 10.1177/14604582221135427.

引用本文的文献

1
Evaluating machine learning models for post-surgery treatment response assessment in glioblastoma multiforme: a comparative study of gray level co-occurrence matrix (GLCM), curvelet, and combined radiomics features selected by multiple algorithms.评估用于多形性胶质母细胞瘤术后治疗反应评估的机器学习模型:灰度共生矩阵(GLCM)、曲波变换以及多种算法选择的联合放射组学特征的比较研究
BMC Med Imaging. 2025 Sep 1;25(1):362. doi: 10.1186/s12880-025-01906-8.
2
Role of artificial intelligence in cancer detection using protein p53: A Review.人工智能在利用蛋白质p53进行癌症检测中的作用:综述
Mol Biol Rep. 2024 Dec 11;52(1):46. doi: 10.1007/s11033-024-10051-4.
3

本文引用的文献

1
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.用于低级别胶质瘤生存风险分层和预后的新型免疫相关基因特征
Front Genet. 2020 Apr 15;11:363. doi: 10.3389/fgene.2020.00363. eCollection 2020.
2
Advancements in predicting outcomes in patients with glioma: a surgical perspective.预测胶质母细胞瘤患者预后的进展:手术视角。
Expert Rev Anticancer Ther. 2020 Mar;20(3):167-177. doi: 10.1080/14737140.2020.1735367. Epub 2020 Mar 2.
3
Machine Learning Algorithms for Predicting the Recurrence of Stage IV Colorectal Cancer After Tumor Resection.
Deep learning in precision medicine and focus on glioma.
精准医学中的深度学习与对神经胶质瘤的关注。
Bioeng Transl Med. 2023 May 31;8(5):e10553. doi: 10.1002/btm2.10553. eCollection 2023 Sep.
4
Cuproptosis-related risk score based on machine learning algorithm predicts prognosis and characterizes tumor microenvironment in head and neck squamous carcinomas.基于机器学习算法的铜死亡相关风险评分可预测头颈部鳞状细胞癌的预后并描绘肿瘤微环境特征。
Sci Rep. 2023 Jul 22;13(1):11870. doi: 10.1038/s41598-023-38060-6.
机器学习算法预测肿瘤切除后 IV 期结直肠癌的复发。
Sci Rep. 2020 Feb 13;10(1):2519. doi: 10.1038/s41598-020-59115-y.
4
Deep Transfer Learning and Radiomics Feature Prediction of Survival of Patients with High-Grade Gliomas.深度学习和放射组学特征预测高级别脑胶质瘤患者的生存。
AJNR Am J Neuroradiol. 2020 Jan;41(1):40-48. doi: 10.3174/ajnr.A6365. Epub 2019 Dec 19.
5
Supervised Machine Learning Predictive Analytics For Triple-Negative Breast Cancer Death Outcomes.用于三阴性乳腺癌死亡结局的监督式机器学习预测分析
Onco Targets Ther. 2019 Nov 1;12:9059-9067. doi: 10.2147/OTT.S223603. eCollection 2019.
6
An independently validated survival nomogram for lower-grade glioma.用于低级别胶质瘤的独立验证生存列线图。
Neuro Oncol. 2020 May 15;22(5):665-674. doi: 10.1093/neuonc/noz191.
7
Characteristics and prognostic factors of age-stratified high-grade intracranial glioma patients: A population-based analysis.基于人群分析的年龄分层高级别颅内胶质瘤患者的特征和预后因素。
Bosn J Basic Med Sci. 2019 Nov 8;19(4):375-383. doi: 10.17305/bjbms.2019.4213.
8
Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis.定义低级别胶质瘤的中危组:一项国家癌症数据库分析。
Anticancer Res. 2019 Jun;39(6):2911-2918. doi: 10.21873/anticanres.13420.
9
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.CBTRUS统计报告:2011 - 2015年美国原发性脑肿瘤及其他中枢神经系统肿瘤诊断情况
Neuro Oncol. 2018 Oct 1;20(suppl_4):iv1-iv86. doi: 10.1093/neuonc/noy131.
10
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial.MGMT 启动子甲基化状态与接受放疗和替莫唑胺治疗的高危胶质瘤患者生存结局的相关性:来自 NRG 肿瘤学/RTOG 0424 试验的分析。
JAMA Oncol. 2018 Oct 1;4(10):1405-1409. doi: 10.1001/jamaoncol.2018.1977.